Mycobacterium scrofulaceum

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 26.02.2023

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Atypical mycobacterium found in milk, oysters, soil and water. M. scrofulaceum is a rare pathogen of the slow-growing nontuberculous mycobacteria (NTMs) family. M. scrofulaceum can infect any tissue in humans.

In children, the pathogen is found clustered in pediatric cervical lymphadenitis. In adult patients, pulmonary infections are prominent (Suzuki S et al. 2016; Wilson JW et al. 2019) .

ManifestationThis section has been translated automatically.

Occurring mainly in childhood, after weaning.

In adults, predominantly middle-aged and older men.

Clinical pictureThis section has been translated automatically.

Childhood: Cervical lymphadenitis, colliquative skin lesions.

Adulthood: Mostly chronic obstructive pulmonary diseases are present, not infrequently with histories of pulmonary tuberculosis. Frequently, the pathogen has been found in South African gold mine workers (Corbett EL et al 1999). In a major microbiology center, positive M. scrofulaceum cultures were identified in 17 patients over a 15-year period. 10x this finding was associated with clinical infection. These were:

  • Pulmonary and pleural infections (4).
  • Bone and joint infections with foreign bodies (2)
  • Skin and soft tissue infections (2) - clinically uncharacteristic abscessing inflammations.
  • brain abscesses (1)
  • pediatric cervical adenitis (1).

Immunomodulatory conditions were present in almost all adult patients. Patients with pulmonary or pleural infections frequently had structural lung disease. Disseminated infections by M. scrofulaceum have been observed in HIV-infected individuals (Sanders JW et al 1995). In contrast, M. scrofulaceum is isolated in about 1/3 of patients in urine or respiratory cultures without evidence of clinical disease.

TherapyThis section has been translated automatically.

Treatment outcomes are generally favorable; however, prognosis is more guarded in patients with pulmonary M. scrofulaceum disease (Wilson JW et al 2019).

LiteratureThis section has been translated automatically.

  1. Corbett EL et al (1999) Mycobacterium kansasii and M. scrofulaceum isolates from HIV-negative South African gold miners: incidence, clinical significance and radiology. Int J Tuberc Lung Dis 3:501-517.
  2. Ishii N et al (1998) A case of mycobacterial skin disease caused by Mycobacterium peregrinum and M. scrofulaceum. Acta Derm Venereol 78:76-77.
  3. Sanders JW et al (1995) Disseminated Mycobacterium scrofulaceum infection: a potentially treatable complication of AIDS. Clin Infect Dis 20: 549.
  4. Suzuki S et al (2016) Clinical characteristics of pulmonary Mycobacterium scrofulaceum disease in 2001-2011: A case series and literature review. J Infect Chemother 22:611-616.
  5. Wilson JW et al (2019) Mycobacterium scrofulaceum disease: experience from a tertiary medical centre and review of the literature. Infect Dis (Lond) 51:602-609.

Authors

Last updated on: 26.02.2023